Azithromycin and Retinal vessel occlusion - a phase IV clinical study of FDA data

Summary:

Retinal vessel occlusion is reported as a side effect among people who take Azithromycin (azithromycin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Aspirin, and have Bone disorder.

The phase IV clinical study analyzes which people have Retinal vessel occlusion when taking Azithromycin. It is created by eHealthMe based on reports of 38,326 people who have side effects when taking Azithromycin from the FDA, and is updated regularly.

What is Azithromycin?

Azithromycin has active ingredients of azithromycin. It is often used in sinusitis. eHealthMe is studying from 40,716 Azithromycin users. Check the latest studies of Azithromycin.

What is Retinal vessel occlusion?

Retinal vessel occlusion (a blockage in one of the small arteries) is found to be associated with 468 drugs and 830 conditions by eHealthMe. Check the latest studies of Retinal vessel occlusion.

On Jul, 28, 2026

38,326 people reported to have side effects when taking Azithromycin.
Among them, 11 people (0.03%) have Retinal vessel occlusion.

Could Azithromycin cause Retinal vessel occlusion?

Among these 11 people:

How long have people been on Azithromycin when they have Retinal vessel occlusion? *

What is the gender of people who have Retinal vessel occlusion when taking Azithromycin? *

female: 63.64 %
male: 36.36 %

What is the age of people who have Retinal vessel occlusion when taking Azithromycin? *

What are other drugs people take besides Azithromycin? *

What are other side effects people have besides Retinal vessel occlusion? *

Weakness: 4 people, 36.36%
Stress And Anxiety: 4 people, 36.36%
Ejection Fraction Decreased (systolic heart failure): 3 people, 27.27%
Deformity (disfigurement): 3 people, 27.27%
Dehydration (dryness resulting from the removal of water): 3 people, 27.27%
Dermatitis Contact (skin reaction (dermatitis) resulting from exposure to allergens): 3 people, 27.27%
Dilatation Ventricular: 3 people, 27.27%
Discomfort: 3 people, 27.27%
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall): 3 people, 27.27%
Dizziness: 3 people, 27.27%

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 3 people, 27.27%
Bone Disorder: 3 people, 27.27%
Prostate Cancer Metastatic: 2 people, 18.18%
High Blood Pressure: 2 people, 18.18%
Waldenstrom's Macroglobulinaemia (cancer affects small lymphocytes (white blood cells)): 1 person, 9.09%
Urinary Tract Infection: 1 person, 9.09%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 9.09%
Multiple Myeloma (cancer of the plasma cells): 1 person, 9.09%
Metastases To Prostate (cancer spreads to prostate): 1 person, 9.09%
Birth Control: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Azithromycin and have Retinal vessel occlusion?

- Check whether Retinal vessel occlusion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Azithromycin:

Azithromycin (40,716 reports)

Browse all side effects of Azithromycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Retinal vessel occlusion:

Retinal vessel occlusion (468 drugs)

Browse all the conditions that are associated with Retinal vessel occlusion:

Retinal vessel occlusion (830 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on azithromycin (the active ingredients of Azithromycin) and Azithromycin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.